Overview
Why Invest
Profitable specialty pharmaceutical company with a diversified portfolio
Cipher’s lean operating structure and collaborative approach to commercialization and development enable rapid and efficient scaling while maximizing our profitability.
- Solid dermatology platform
- Established presence across the Americas
- Strong balance sheet
- History of positive operating cash flow
- Robust pipeline
- Proven leadership team
Ticker
TSXCPH
Q3 2024 Results
IR Contact